<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75732">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02150044</url>
  </required_header>
  <id_info>
    <org_study_id>CPR005008</org_study_id>
    <nct_id>NCT02150044</nct_id>
  </id_info>
  <brief_title>Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion</brief_title>
  <acronym>inVENT2</acronym>
  <official_title>A Clinical Study of the Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion for Otitis Media</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acclarent</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acclarent</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a non-significant risk (NSR), prospective, multi-center, single arm clinical trial
      that aimed to evaluate safety and performance of the Acclarent Tympanostomy Tube Delivery
      System (TTDS).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Ear Outcome success</measure>
    <time_frame>Day 0</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The composite endpoint, Ear Outcome Success, is comprised of Device Success with no Safety Events (per ear).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure Success:</measure>
    <time_frame>Day 0</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Procedure Success: on per subject basis, is the successful placement of any tympanostomy tube in the absence of Safety Events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tube Retention</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Tube Retention: on per device basis, is the presence of a TTDS-placed tympanostomy tube across the tympanic membrane (TM) at the Follow-Up visit</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Otitis Media</condition>
  <arm_group>
    <arm_group_label>Tympanostomy tube</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Performance and safety of tympanostomy tube delivery system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acclarent Tympanostomy Tube Delivery System (TTDS).</intervention_name>
    <description>tympanostomy tube delivery system</description>
    <arm_group_label>Tympanostomy tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with either chronic otitis media with effusion (OME) or recurrent acute
             otitis media (AOM) and scheduled to undergo tympanostomy tube insertion

        Exclusion Criteria:

          -  History of sensitivity or reaction to anesthesia chosen for the procedure

          -  Markedly atrophic, mono- or bimeric, severely retracted, atelectatic or perforated
             tympanic membrane

          -  Otitis externa

          -  Active acute otitis media

          -  Otitis media pathology requiring T-tubes

          -  Stenosed ear canal

          -  Anatomy that precludes sufficient visualization of and access to the tympanic
             membrane

          -  Anatomy that necessitates tympanostomy tube placement in the posterior half of the
             tympanic membrane
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Port St. Lucie</city>
        <state>Florida</state>
        <zip>34952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Biloxi</city>
        <state>Mississippi</state>
        <zip>39564</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>May 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
